Stock News

There are thousands of news produced and distributed by media outlets every day and a huge amount of PR communication released by stock listed companies, which together can keep you busy for far too long. But only a small part of these stock news deliver investor’s value. Our aim is to aggregate headlines and rank them by their impact on stocks’ movement. This way we do the dirty job of extracting news which are valuable and potentially significant, and put them in the appropriate context of stock listed companies which you are interested in.

The 4 Top Cryptocurrency Mining Stocks fool.com
The 4 Top Cryptocurrency Mining Stocks fool.com
Kohl's Stock Still Has Huge Upside fool.com
These 2 Regional Banks Just Beat Earnings -- Here's Why They Could Still Be Bargains fool.com
These 2 Regional Banks Just Beat Earnings -- Here's Why They Could Still Be Bargains fool.com
Now's the Time to Buy These Stocks fool.com
Now's the Time to Buy These Stocks fool.com
Now's the Time to Buy These Stocks fool.com
Why Is Biogen Inc. Giving Ionis Another $1 Billion? fool.com
Why Is Biogen Inc. Giving Ionis Another $1 Billion? fool.com
Can Cameco Corp.'s Dividend Even Survive? fool.com
Why You're Smart to Buy This Beaten-Up Dividend Stock fool.com
Why You're Smart to Buy This Beaten-Up Dividend Stock fool.com
Kamada shares drop on FDA's continued concerns about therapy's safety, trial delay marketwatch.com
It's Not Too Late to Buy Textron fool.com
It's Not Too Late to Buy Textron fool.com
Humana-led consortium to acquire privately held Curo Health Services in $1.4 billion deal marketwatch.com
Humana-led consortium to acquire privately held Curo Health Services in $1.4 billion deal marketwatch.com
Hasbro shares nose-dive after lackluster earnings report; company blames Toys R Us liquidation cnbc.com
Hasbro shares nose-dive after lackluster earnings report; company blames Toys R Us liquidation cnbc.com
Akorn's stock plunged toward 5-year low after Fresenius terminates merger deal marketwatch.com
Elaine Wynn urges Wynn shareholders to remove director John Hagenbuch marketwatch.com
CenterPoint Energy to buy Vectren for $72 a share marketwatch.com
CenterPoint Energy to buy Vectren for $72 a share marketwatch.com
Aluminum Consumers Pose A Not-Unreasonable Question: How High Can Prices Go? seekingalpha.com
Aluminum Consumers Pose A Not-Unreasonable Question: How High Can Prices Go? seekingalpha.com
This Big Balanced Fund Is Getting Better morningstar.com
This Big Balanced Fund Is Getting Better morningstar.com
This Big Balanced Fund Is Getting Better morningstar.com
Model Retirement Saver Portfolios for T. Rowe Price Investors morningstar.com
Henry Schein plans animal health spinoff, expects more than $1 bln marketwatch.com
Halliburton revenue jumps 34% cnbc.com
Halliburton revenue jumps 34% cnbc.com
Halliburton swings to profit in first quarter marketwatch.com
Hasbro's stock falls after adjusted profit, sales miss expectations marketwatch.com
Hasbro's stock falls after adjusted profit, sales miss expectations marketwatch.com
The Market Should Be Growing - Why Is It Still Down From January? seekingalpha.com
The Market Should Be Growing - Why Is It Still Down From January? seekingalpha.com
After Struggling for Years, Is This Renewable Dividend a Buy? fool.com
Why I'm Taking Profits On Alphabet Ahead Of Earnings seekingalpha.com
Why I'm Taking Profits On Alphabet Ahead Of Earnings seekingalpha.com
GE: The Turnaround Strengthens seekingalpha.com
IBM Avoids Facing Reality, Shareholders Need To Act Now seekingalpha.com
IBM Avoids Facing Reality, Shareholders Need To Act Now seekingalpha.com
IBM Avoids Facing Reality, Shareholders Need To Act Now seekingalpha.com
Darden (DRI) Up 6% Since Earnings Report: Can It Continue? zacks.com
Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma's Major Support By Panel seekingalpha.com
Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma's Major Support By Panel seekingalpha.com
Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma's Major Support By Panel seekingalpha.com
Micron (MU) Down 14.1% Since Earnings Report: Can It Rebound? zacks.com